Bigbear Pharmaceutical·Medication Guide

• Common Side Effects of Erdafitinib

  Erdafitinib, an FGFR inhibitor, may cause various adverse reactions when used to treat urothelial carcinoma with FGFR gene abnormalities.I. Common Sid···【Read More】

  Update: 2026-04-07Source: Haiou HealthViews: 92

• Erdafitinib Dosage and Administration

  Erdafitinib, an FGFR inhibitor, is used to treat urothelial carcinoma with specific gene abnormalities.I. Erdafitinib Dosage and Administration1. Stan···【Read More】

  Update: 2026-04-07Source: Haiou HealthViews: 89

• Erdafitinib Indications

  Erdafitinib is an FGFR-targeting kinase inhibitor used to treat urothelial carcinoma with specific gene abnormalities.I. Erdafitinib Indications1. Uro···【Read More】

  Update: 2026-04-07Source: Haiou HealthViews: 93

• Erdafitinib vs. Chemotherapy: Cost Comparison and Generic Availability Outlook

  The price of erdafitinib is affected by factors such as dosage, region, and health insurance policies, typically ranging from tens of thousands of yua···【Read More】

  Update: 2026-04-07Source: Haiou HealthViews: 92

• Does Medicare or Private Insurance Cover Erdafitinib (Balversa) for Bladder Cancer?

  Erdafitinib is a targeted therapy for specific gene mutations (such as FGFR), primarily used to treat locally advanced or metastatic urothelial carcin···【Read More】

  Update: 2026-04-07Source: Haiou HealthViews: 90

• Erdafitinib (Balversa) Cost Per Month 2026: Full Price & Financial Assistance Options

  The price of erdatinib varies significantly depending on the version, strength, and purchase channel. Original drugs (such as the Johnson & Johnso···【Read More】

  Update: 2026-04-07Source: Haiou HealthViews: 87

• Balversa Receives FDA Approval as First Targeted Therapy for Metastatic Bladder Cancer

  Urothelial carcinoma (UC) is a common type of bladder cancer, accounting for approximately 90% of all bladder cancers. About one-fifth of mUC patients···【Read More】

  Update: 2026-04-07Source: Haiou HealthViews: 95

• Balversa Receives Full FDA Approval for Advanced or Metastatic Urothelial Carcinoma

  The U.S. Food and Drug Administration (FDA) recently granted full approval to Balversa (erdafitinib) for the treatment of adult patients with locally ···【Read More】

  Update: 2026-04-07Source: Haiou HealthViews: 95

• BALVERSA Files Supplemental New Drug Application in the US

  On August 29, Genzo Pharmaceuticals announced that it has filed a supplemental New Drug Application (NDA) with the US Food and Drug Administration (FD···【Read More】

  Update: 2026-04-07Source: Haiou HealthViews: 84

• Other Medications That May Affect Epclusa

  When you begin or stop taking Epclusa, your doctor may need to adjust the dosages of any other medications you take regularly.Certain drugs should not···【Read More】

  Update: 2026-04-07Source: Haiou HealthViews: 85

• What to Avoid While Taking Epclusa

  This medication will not stop your infection from spreading to others. Avoid unprotected sexual intercourse and do not share razors or toothbrushes. C···【Read More】

  Update: 2026-04-07Source: Haiou HealthViews: 88

• What to Do In Case of Epclusa Overdose

  Seek immediate emergency medical care or call the Poison Control Helpline.【Read More】

  Update: 2026-04-07Source: Haiou HealthViews: 91

• What to Do If You Miss a Dose of Epclusa

  Take your dose as soon as you realize you’ve forgotten it, then resume your normal dosing schedule. Do not take a double dose to make up for the misse···【Read More】

  Update: 2026-04-07Source: Haiou HealthViews: 90

• Indications of Epclusa

  Epclusa contains the active ingredients sofosbuvir and velpatasvir as a fixed-dose combination product, indicated for the treatment of chronic hepatit···【Read More】

  Update: 2026-04-07Source: Haiou HealthViews: 89

• Side Effects of Epclusa

  Side Effects of EpclusaUnderstanding the potential side effects of Epclusa helps patients prepare mentally, identify abnormal symptoms in a timely man···【Read More】

  Update: 2026-04-07Source: Haiou HealthViews: 92